Site Map
Product Pages Catalogue Numbers 0601 - 0700
| Cat. No. | Product Name & Pharmacological Action |
|---|---|
| 0601 | Nitrendipine |
| Ca2+ channel blocker (L-type) | |
| 0602 | 7-Nitroindazole |
| Non-selective NOS inhibitor | |
| 0603 | SNOG |
| NO carrier. Breaks down to release NO | |
| 0604 | Nicergoline |
α antagonist |
|
| 0605 | (±)-Octanoylcarnitine chloride |
| Intermediate in lipid metabolism | |
| 0606 | OBAA |
| Phospholipase A2 inhibitor | |
| 0607 | 17-ODYA |
| LTB-ω-Hydroxylase inhibitor | |
| 0609 | (±)-Palmitoylcarnitine chloride |
| Protein kinase C inhibitor | |
| 0610 | Parthenolide |
| 5-HT release inhibitor | |
| 0611 | (±)-Propionylcarnitine chloride |
| Intermediate in lipid metabolism | |
| 0616 | AG 556 |
| EGFR-kinase inhibitor | |
| 0618 | AG 555 |
| Potent EGFR-kinase inhibitor | |
| 0619 | AG 494 |
| Potent EGFR-kinase inhibitor | |
| 0620 | 4-PPBP maleate |
| Specific σ ligand, NMDA antagonist | |
| 0622 | Physostigmine hemisulfate |
Cholinesterase inhibitor |
|
| 0623 | Prazosin hydrochloride |
| α1 antagonist. MT3 antagonist | |
| 0624 | Propranolol hydrochloride |
β antagonist |
|
| 0625 | PPADS tetrasodium salt |
| P2 purinergic antagonist | |
| 0627 | 2-[(4-Phenylpiperazin-1-yl)methyl]-2,3-dihydroimidazo[1,2-c]quinazolin-5(6H)-one |
| Potent, selective α1 antagonist | |
| 0629 | Quipazine dimaleate |
| 5-HT3 agonist | |
| 0630 | Rosmarinic acid |
| Anti-inflammatory, cytostatic and anti-viral | |
| 0631 | Spiroxatrine |
Potent α2 ligand |
|
| 0633 | D-erythro-Sphingosine (synthetic) |
| Protein kinase C inhibitor | |
| 0634 | Salbutamol hemisulfate |
β agonist (β2>β1) |
|
| 0635 | Synthalin sulfate |
| Non-competitive NMDA antagonist | |
| 0636 | Salsolinol-1-carboxylic acid |
| Endogenous amino acid | |
| 0638 | CGS 12066B dimaleate |
| 5-HT1B agonist | |
| 0640 | MDL 72222 |
| 5-HT3 antagonist | |
| 0641 | Tropanyl-3,5-dimethylbenzoate |
| 5-HT3 antagonist | |
| 0644 | Thioperamide maleate |
| H3/H4 antagonist, active in vivo | |
| 0645 | 2-(1-Thienyl)ethyl 3,4-dihydroxybenzylidenecyanoacetate |
| 5-, 12-, 15-Lipoxygenase inhibitor | |
| 0646 | HTMT dimaleate |
| H1 / H2 agonist | |
| 0649 | (S)-Timolol maleate |
β1 antagonist |
|
| 0650 | Trimethoprim |
| Dihydrofolate reductase inhibitor | |
| 0652 | Thalidomide |
| TNF-α synthesis inhibitor | |
| 0653 | (±)-Vesamicol hydrochloride |
Inhibits ACh transport |
|
| 0654 | Verapamil hydrochloride |
| Ca2+ channel blocker (L-type) | |
| 0655 | Zolpidem |
| Benzodiazepine agonist | |
| 0658 | FGIN-1-27 |
| Potent, specific ligand for mitochondrial DBI receptor | |
| 0659 | FGIN-1-43 |
| Potent, specific ligand for mitochondrial DBI receptor | |
| 0660 | Mepyramine maleate |
| Selective H1 inverse agonist | |
| 0661 | 2-[[4-(2-Methoxyphenyl)piperazin-1-yl] methyl]-6-methyl-2,3-dihydroimidazo[1,2c]quinazolin-5(6H)-one |
| Potent, selective α1 antagonist and σ2 ligand | |
| 0662 | trans-Triprolidine hydrochloride |
| Standard H1 antagonist, highly potent | |
| 0663 | L-Arginine |
| Endogenous substrate for NOS | |
| 0664 | L-NNA |
| NOS inhibitor (nNOS = eNOS >> iNOS) | |
| 0665 | L-NAME hydrochloride |
| Non-selective NOS inhibitor | |
| 0666 | 3-(4-Allylpiperazin-1-yl)-2-quinoxalinecarbonitrile maleate |
| 5-HT3 antagonist | |
| 0668 | Amthamine dihydrobromide |
| Highly selective standard H2 agonist | |
| 0670 | PK 11195 |
| Antagonist at peripheral BDZ receptors | |
| 0671 | AH 6809 |
| EP1 and EP2 receptor antagonist | |
| 0673 | L-Canavanine sulfate |
| iNOS inhibitor | |
| 0674 | Dequalinium dichloride |
| K+ channel blocker (SKCa) | |
| 0675 | NPC 15199 |
| Novel anti-inflammatory agent | |
| 0677 | Naltrexone hydrochloride |
| Broad spectrum opioid antagonist | |
| 0678 | (+)-AJ 76 hydrochloride |
Antagonist; preferential action at D2-like autoreceptors |
|
| 0680 | 2-Phenylmelatonin |
| Potent melatonin agonist | |
| 0681 | L-690,330 |
| Inositol monophosphatase inhibitor | |
| 0682 | L-690,488 |
| Cell permeable prodrug of the IMPase inhibitor L-690,330 (Cat. No. 0681) | |
| 0683 | iso-PPADS tetrasodium salt |
| P2X purinergic antagonist | |
| 0684 | (±)-Epibatidine |
Very potent nicotinic agonist |
|
| 0685 | Diltiazem hydrochloride |
| Ca2+ channel blocker (L-type) | |
| 0686 | Galanthamine hydrobromide |
Cholinesterase inhibitor |
|
| 0687 | Danazol |
Anterior pituitary suppressant |
|
| 0690 | Clonidine hydrochloride |
| α2 agonist. Also I1 ligand | |
| 0691 | Dipyridamole |
| Adenosine transport inhibitor | |
| 0692 | Ipratropium bromide |
Muscarinic antagonist |
|
| 0693 | Pancuronium dibromide |
Nicotinic (neuromuscular) antagonist |
|
| 0694 | Pilocarpine hydrochloride |
Muscarinic agonist |
|
| 0695 | Retinoic acid |
| Endogenous retinoic acid receptor agonist. Also modulates PPARδ | |
| 0699 | BRL 52537 hydrochloride |
| Potent and selective κ agonist | |
| 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | All |
[top]